Business
Shanghai Kehua Bio-engineering Product Pipeline Analysis Report 2025: Opportunities in IVD Devices, Leveraging Partnerships for R&D Innovation in Diagnostics and Point-of-care Testing
Kehua Bio offers significant market opportunities in IVD devices, leveraging partnerships for R&D innovation in diagnostics and point-of-care testing. Its...
About this update from Shanghai Kehua Bio-engineering Co., Ltd. Class A
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Kehua Bio offers significant market opportunities in IVD devices, leveraging partnerships for R&D innovation in diagnostics and point-of-care testing. Its established manufacturing and sales presence enables market expansion, while strategic insights into competitor pipelines aid in sharpening competitive and M&A strategies.","length":334,"tagName":"p"},{"type":"text","content":"Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "Shanghai Kehua Bio-engineering Co Ltd (002022) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering.","length":203,"tagName":"p"},{"type":"text","content":"Shanghai Kehua Bio-engineering Co Ltd (KHB) is a leading developer, manufacturer, and marketer of in vitro diagnostic (IVD) devices and associated products. KHB specializes in diagnostic reagents and instruments across key areas such as biochemical diagnostics, immunodiagnostics, molecular diagnostics, and point-of-care testing. These products are vital for clinical diagnosis, treatment, blood screening, public health initiatives, food safety, and scientific research.","length":472,"tagName":"p"},{"type":"text","content":"Highlighting KHB's commitment to innovation, the company has formed strategic partnerships with prominent international firms to boost its research and development (R&D) capabilities. KHB operates R&D and manufacturing facilities in Italy, Shenzhen, Xi'an, and Suzhou, with sales support located in major Chinese cities. Its products are distributed domestically and internationally, cementing KHB's global market presence. The company is headquartered in Shanghai, China.","length":492,"tagName":"p"},{"type":"text","content":"This report serves as a comprehensive source for data, analysis, and actionable intelligence concerning KHB's portfolio and pipe...
More updates from Shanghai Kehua Bio-engineering Co., Ltd. Class A